AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Autoimmune Encephalitis

Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease NCT06515106NA1 site📍 Barcelona Fundacion Clinic per a la Recerca Biomédica · Tests: Remote cognitive rehabilitation program Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia NCT07732907n/a1 site📍 Lawrenceville Bristol-Myers Squibb · Tests: Ozanimod Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis NCT03993262Phase 217 sites📍 München📍 Würzburg📍 Jena Jena University Hospital · Tests: Bortezomib, Placebo Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection NCT05198661NA62 sites📍 Pointe à Pitre📍 Aix-en-Provence📍 Amiens Hospices Civils de Lyon · Tests: Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma. CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases NCT07337785EARLY Phase 11 site📍 Wuhan Tongji Hospital · Tests: CD19/BCMA-targeted CAR-T cells, Lymphodepleting Conditioning A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis NCT06173076n/a1 site📍 Hangzhou Shen Chun-Hong Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis) NCT06584045NA1 site📍 Wuhan Tongji Hospital · Tests: Calculus bovis sativus (CBS) OPM- MEG in Non-immune And iMmune-medIated Neurological Disease NCT07689682NA2 sites📍 Birmingham📍 Birmingham Aston University · Tests: OPM- Magnetoencephalography Medium-term Effects of Treatments in Autoimmune Encephalitis NCT07133113n/a1 site📍 Bron Hospices Civils de Lyon · Tests: We aim to assess the clinical response to the treatment initiation protocols most commonly used in autoimmune encephali… A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease NCT07093333Phase 21 site📍 Seoul Arialys Australia Pty Ltd · Tests: ART5803, ART5803-Cohort D Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology NCT06388161n/a1 site📍 Hangzhou Shen Chun-Hong Biomarkers in Autoimmune Disease of Nervous System NCT06502015n/a1 site📍 Wuhan Tongji Hospital · Tests: biomaker levels Cohort Study on Neuroimmune Diseases in the Reproductive Age NCT07653984n/a1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis NCT06867991Phase 32 sites📍 Zhengzhou📍 Changzhou The First People's Hospital of Changzhou · Tests: Ofatumumab combined with daratumumab, Ofatumumab, Repeated intravenous immunoglobulin/plasma exchange therapy Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism NCT06079294NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: FDG PET Long-term Impact of NMDAR Encephalitis, Level 3 NCT07158229n/a1 site📍 Bron Hospices Civils de Lyon · Tests: Questionnaires Efgartigimod in Anti-NMDA Receptor Encephalitis. NCT07822776Phase 21 site📍 Beijing Beijing Tongren Hospital · Tests: Efgartigimod Alfa Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis NCT06510283Phase 21 site📍 Beijing Beijing Tongren Hospital · Tests: Taitacept Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. NCT07526493Phase 11 site📍 Wuhan Tongji Hospital · Tests: Universal CD19 CAR-γδT Cell Injection, Cyclophosphamide, Fludarabine Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis NCT04421846NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Blood sampling, cerebrospinal fluid , post-mortem cerebral tissues (NA for the Group 3), Blood sampling, cerebrospinal … FDG-PET in the Diagnosis of Autoimmune Encephalitis NCT06019975n/a6 sites📍 Udine📍 Genoa📍 Pavia University of Milano Bicocca · Tests: FDG-PET Natural History Study of Progressive Multifocal Leukoencephalopathy (PML) NCT01730131n/a1 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis NCT07477015n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis NCT04372615Phase 239 sites📍 Birmingham📍 Phoenix📍 Scottsdale University of Utah · Tests: Inebilizumab, Placebo High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network NCT06863974NA8 sites📍 Angers📍 Brest📍 Le Kremlin-Bicêtre University Hospital, Angers · Tests: Blood test Lupus Landmark Study: A Prospective Registry and Biorepository NCT05934149n/a25 sites📍 Birmingham📍 Tucson📍 Beverly Hills Lupus Research Alliance Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis? NCT07488117Phase 21 site📍 Toulouse University Hospital, Toulouse · Tests: TEP with radioligand EAI 714 Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies NCT06941584n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Test for AQP4, AChR, LGI1, and CASPR2 autoantibodies using cell-based assay, AIRE single gene sequencing, Molecular typ… Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy NCT05849467Phase 11 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… · Tests: 89 Zr-Df-crefmirlimab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy